Indiana 2024 Regular Session

Indiana House Bill HB1182 Latest Draft

Bill / Enrolled Version Filed 02/22/2024

                            Second Regular Session of the 123rd General Assembly (2024)
PRINTING CODE. Amendments: Whenever an existing statute (or a section of the Indiana
Constitution) is being amended, the text of the existing provision will appear in this style type,
additions will appear in this style type, and deletions will appear in this style type.
  Additions: Whenever a new statutory provision is being enacted (or a new constitutional
provision adopted), the text of the new provision will appear in  this  style  type. Also, the
word NEW will appear in that style type in the introductory clause of each SECTION that adds
a new provision to the Indiana Code or the Indiana Constitution.
  Conflict reconciliation: Text in a statute in this style type or this style type reconciles conflicts
between statutes enacted by the 2023 Regular Session of the General Assembly.
HOUSE ENROLLED ACT No. 1182
AN ACT to amend the Indiana Code concerning criminal law and
procedure.
Be it enacted by the General Assembly of the State of Indiana:
SECTION 1. IC 4-22-2.3-8, AS ADDED BY P.L.249-2023,
SECTION 43, IS AMENDED TO READ AS FOLLOWS [EFFECTIVE
UPON PASSAGE]: Sec. 8. (a) The Indiana board of pharmacy, on its
own initiative or under a written request from the state police
department, the United States Drug Enforcement Administration,
or a poison control center, may adopt interim rules under
IC 4-22-2-37.2 to declare a substance is a synthetic drug if the board
finds that the substance:
(1) has been scheduled or emergency scheduled by the United
States Drug Enforcement Administration;
(2) has been scheduled, emergency scheduled, or criminalized by
another state; or
(3) has:
(A) a high potential for abuse; and
(B) no accepted medical use in treatment in the United States
or lacks accepted safety for use in treatment under medical
supervision.
(b) In making a determination under subsection (a)(3), the Indiana
board of pharmacy shall consider the following factors described in
IC 25-26-13-4.1. relating to the substance:
(1) The actual or relative potential for abuse.
HEA 1182 — Concur 2
(2) Scientific evidence of the substance's pharmacological
effect, if known.
(3) The state of scientific knowledge regarding the substance.
(4) The history and current pattern of abuse of the substance.
(5) The scope, duration, and significance of abuse of the
substance.
(6) The degree of risk to the public health.
(7) The psychic or psychological dependence liability of the
substance.
(c) Notwithstanding IC 4-22-2-37.2(i), a rule described in this
section becomes effective when the rule is published in the Indiana
Register. A rule described in this section expires not later than one (1)
year after June 30 of the year following the year in which the rule is
accepted for filing by the publisher of the Indiana Register and may not
be continued in another interim rule.
SECTION 2. IC 25-26-13-4.1, AS AMENDED BY P.L.196-2013,
SECTION 11, IS AMENDED TO READ AS FOLLOWS [EFFECTIVE
UPON PASSAGE]: Sec. 4.1. (a) The board may adopt an emergency
interim rule to declare that a substance is a synthetic drug in
accordance with the requirements of IC 4-22-2.3-8.
(b) The board may, on its own initiative or under a written request
from the state police department, the United States Drug Enforcement
Administration, or a poison control center, adopt an emergency rule
declaring a substance to be a synthetic drug if the board finds that the
substance:
(1) has been scheduled or emergency scheduled by the United
States Drug Enforcement Administration;
(2) has been scheduled, emergency scheduled, or criminalized by
another state; or
(3) has:
(A) a high potential for abuse; and
(B) no accepted medical use in treatment in the United States
or lacks accepted safety for use in treatment under medical
supervision.
(c) In making its determination under subsection (b)(3), the board
shall consider the following factors relating to the substance:
(1) The actual or relative potential for abuse.
(2) Scientific evidence of the substance's pharmacological effect,
if known.
(3) The state of current scientific knowledge regarding the
substance.
(4) The history and current pattern of abuse of the substance.
HEA 1182 — Concur 3
(5) The scope, duration, and significance of abuse of the
substance.
(6) The degree of risk to the public health.
(7) The psychic or psychological dependence liability of the
substance.
(d) A rule adopted under this section becomes effective thirty (30)
days after it is filed with the publisher under IC 4-22-2-37.1.
(e) A rule adopted under this section expires on June 30 of the year
following the year in which it is filed with the publisher under
IC 4-22-2-37.1.
(f) The board may readopt under this section an emergency rule that
has expired.
SECTION 3. IC 35-48-2-4, AS AMENDED BY P.L.48-2023,
SECTION 4, IS AMENDED TO READ AS FOLLOWS [EFFECTIVE
JULY 1, 2024]: Sec. 4. (a) The controlled substances listed in this
section are included in schedule I.
(b) Opiates. Any of the following opiates, including their isomers,
esters, ethers, salts, and salts of isomers, esters, and ethers, unless
specifically excepted by rule of the board or unless listed in another
schedule, whenever the existence of these isomers, esters, ethers, and
salts is possible within the specific chemical designation:
4-fluoroisobutyryl fentanyl
Acetyl-alpha-methylfentanyl (N-[1-(1-methyl-2-phenethyl)-4-
piperidinyl]-N-phenylacetamide) (9815)
Acetyl fentanyl (Other names include:
N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide)
Acetylmethadol (9601)
Acrylfentanyl. Other name: N-(1-phenethylpiperidin-4-yl)-
N-phenylacrylamide
Allylprodine (9602)
Alpha-methylthiofentanyl (N-[1-methyl-2-(2-
thienyl)ethyl-4-piperidinyl]-N-phenylpropanamide) (9832)
Alphacetylmethadol (9603)
Alphameprodine (9604)
Alphamethadol (9605)
Alpha'-Methyl butyryl fentanyl (2-methyl-N-(1-
phenethylpiperidin- 4-yl)-N-phenylbutanamide) (9864)
Alphamethylfentanyl (9814)
Benzethidine (9606)
Beta-hydroxy-3-methylfentanyl (9831). Other name:
N-[1-(2-hydroxy-2-phenethyl)-3-methyl-4-piperidinyl
]-N-phenylpropanamide
HEA 1182 — Concur 4
Beta-hydroxyfentanyl (N-[1-(2-hydroxy-2-
phenethyl)-4-piperidinyl]-N-phenylpropanamide) (9830)
Betacetylmethadol (9607)
Betameprodine (9608)
Betamethadol (9609)
Betaprodine (9611)
Brorphine(9098). Other name:
1-(1-(1-(4-bromophenyl)ethyl)piperidin-4-yl)-1,3-dihydro-2
H-benzo[d]imidazol-2-one
2-(2-(4-butoxybenzyl)-5-nitro-1H-benzimidazol-1yl)-N,N-dieth
ylethan-1-amine (butonitazene); other name: butoxynitazene
Clonitazene (9612)
Cyclopentyl fentanyl. Other name:
N-(1-phenethylpiperidin-4-yl)-N-phenylcyclopentanecarboxamide
Dextromoramide (9613)
Diampromide (9615)
Diethylthiambutene (9616)
N,N-diethyl-2-(2-(4-flourobenzyl)-5-nitro-1H-benzimidazol-1-y
l)ethan-1-amine (flunitazene)
N,N-diethyl-2-(2-(4-methoxybenzyl)-1H-benzimidazol-1-yl)eth
an-1-amine (metodesnitazene)
N,N-diethyl-2-(2-(4-methoxybenzyl)-5-nitro-1H-benzimidazol-
1-yl)ethan-1-amine (metonitazene)
N,N-diethyl-2-(5-nitro-2-(4-propoxybenzyl)-1H-benzimidazol-
1-yl)ethan-1-amine (protonitazene); other name: pronitazene
Difenoxin (9168)
Dimenoxadol (9617)
Dimepheptanol (9618)
2',5'-Dimethoxyfentanyl (N-(1- (2,5-dimethoxyphenethyl)
piperidin-4-yl)- N-phenylpropionamide) (9861)
Dimethylthiambutene (9619)
Dioxaphetyl butyrate (9621)
Dipipanone (9622)
2-(2-(4-ethoxybenzyl)-1H-benzimidazol-1yl)-N,N-diethylethan-
1-amine (etodesnitazene; etazene)
2-(4-ethnoxybenzyl)5-nitro-1(2-(pyrorolidin-1-yl)ethyl)-1H-ben
zimidazol (N-pyrrolidino etonizatene; etonitazepyne)
Ethylmethylthiambutene (9623)
Etonitazene (9624)
Etoxeridine (9625)
Fentanyl related substances.
Furanyl fentanyl (N-(1-phenethylpiperidin- 4-yl)-
HEA 1182 — Concur 5
N-phenylfuran- 2-carboxamide) (9834)
3-Furanyl fentanyl (N-(1-phenethylpiperidin- 4-yl)-
N-phenylfuran- 3- carboxamide) (9860)
Furethidine (9626)
Hydroxypethidine (9627)
Isobutyryl fentanyl. Other name:
N-(1-phenethylpiperidin-4-yl)-N-phenylisobutyramide
Isotonitazene. Other name: N,N-diethyl-2-
(2-(4 isopropoxybenzyl)-5-nitro-1H-benzimidazol-
1-yl)ethan-1-amine)
Isovaleryl fentanyl (3-methyl- N-(1-phenethylpiperidin-4-yl)-
N- phenylbutanamide) (9862)
Ketobemidone (9628)
Levomoramide (9629)
Levophenacylmorphan (9631)
Meta-Fluorofentanyl (N-(3- fluorophenyl)- N-
(1-phenethylpiperidin-4-yl) propionamide) (9857)
Meta-Fluoroisobutyryl fentanyl (N-(3-fluorophenyl)- N-
(1-phenethylpiperidin-4-yl) isobutyramide) (9858)
Methoxyacetyl fentanyl. Other name:
2-methoxy-N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide
3-Methylfentanyl [N-[3-methyl-1-(2-phenylethyl)-4-
piperidyl]-N-phenyl-propanimide](9813)
3-Methylthiofentanyl (N-[(3-methyl-1-(2-thienyl)ethyl-4-
piperidinyl]-N-phenylpropanamide) (9833)
M etonitazene
(N,N-diethyl-2-(2-(4-methoxybenzyl)-5-nitro-1H-benzimida
zol-1-yl)ethan-1-amine) (9757)
MPPP (1-methyl-4-phenyl-4-propionoxypiperidine) (9961)
Morpheridine (9632)
N-[1-benzyl-4-piperidyl]-N-phenylpropanamide (benzylfentanyl),
including any isomers, salts, or salts of isomers (9818)
N-[1-[2-hydroxy-2-(thiophen-2-yl)ethyl] 25 piperidin-4-yl]-
N-phenylpropionamide, also known as N-[1-[2-hydroxy-2-
(2-thienyl)ethyl] -4- piperidinyl]- N-phenylpropanamide,
(beta-hydroxythiofentanyl)
N-(4-chlorophenyl)- N-(1-phenethylpiperidin-4-yl) isobutyramide
(para-chloroisobutyryl fentanyl)
N-(2-fluorophenyl)-2-methoxy-N-(1-phenethylpiperidin-4-yl)
acetamide (ocfentanil)
N-(4-fluorophenyl)-N-(1-phenethylpiperidin-4 -yl) butyramide
(para-fluorobutyryl fentanyl)
HEA 1182 — Concur 6
N-(1-phenethylpiperidin-4-yl)-N-phenylbutyramide, also known
as N-(1-phenethylpiperidin-4-yl)-N-phenylbutanamide, (butyryl
fentanyl)
N-(1-phenethylpiperidin-4-yl)-N-phenylpentanamide (valeryl
fentanyl)
N-(4-methoxyphenyl)-N-(1-phenethylpiperidin -4-yl) butyramide
(para-methoxybutyryl fentanyl)
N-[1-(2-thienyl)methyl-4-piperidyl]-N-phenylpropanamide
(thenylfentanyl), including any isomers, salts, or salts of isomers
(9834)
N-(1-phenethylpiperidin-4-yl)-N-phenylisobutyramide (isobutyryl
fentanyl)
N-(1-phenethylpiperidin-4-yl)- Nphenylcyclopentanecarboxamide
(cyclopentyl fentanyl)
Noracymethadol (9633)
Norlevorphanol (9634)
Normethadone (9635)
Norpipanone (9636)
Ocfentanil. Other name:
N-(2-fluorophenyl)-2-methoxy-N-(1-phenethylpiperidin-4-yl)
acetamide
Ortho-fluorofentanyl or 2-fluorofentanyl. Other name:
N-(2-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)propionamide
Ortho-Fluorofuranyl fentanyl (N-(2-fluorophenyl)- N-
(1-phenethylpiperidin-4-yl)furan-2-carboxamide) (9863)
Para-chloroisobutyryl fentanyl. Other name:
N-(4-chlorophenyl)-N-(1-phenethylpiperidin-4-yl)isobutyramide
Para-fluorobutyryl fentanyl. Other name:
N-(4-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)butyramide
Para-fluorofentanyl (N-(4-fluorophenyl)-N-
[1-(2-phenethyl)-4-piperidinyl] propanamide (9812)
Para-methoxybutyryl fentanyl. Other name:
N-(4-methoxyphenyl)-N-(1-phenethylpiperidin-4-yl)butyramide
Para-Methoxyfuranyl fentanyl (N-(4-methoxyphenyl)- N-
(1-phenethylpiperidin-4-yl) furan-2-carboxamide (9859)
Para-Methylcyclopropyl fentanyl (N-(4-methylphenyl)- N-
(1-phenethylpiperidin- 4-yl)cyclopropanecarboxamide) (9865)
Phenadoxone (9637)
Phenampromide (9638)
Phenomorphan (9647)
Phenoperidine (9641)
PEPAP [1-(2-phenethyl)-4-phenyl-4-acetoxypiperidine] (9663)
HEA 1182 — Concur 7
Piritramide (9642)
Proheptazine (9643)
Properidine (9644)
Propiram (9649)
Racemoramide (9645)
Tetrahydrofuranyl fentanyl. Other name:
N-(1-phenethylpiperidin-4-yl)-N-phenyltetrahydrofuran-2-carb
oxamide
Thiofentanyl (N-phenyl-N-[ 1-(2-thienyl)ethyl-4-
piperidinyl]-propanamide) (9835)
Tianeptine (7-[(3-chloro-6-methyl-5,5-dioxo-11H-benzo[c]
[2,1]benzothiazepin-11-yl)amino]heptanoic acid)
Tilidine (9750)
Trimeperidine (9646)
U47700 (3,4-dichloro- N- [2-dimethylamino)cyclohexyl]-
N-methyl- benzamide)
Valeryl fentanyl. Other name:
N-(1-phenethylpiperidin-4-yl)-N-phenylpentanamide
Zipeprol (1-methoxy-3- [4-(2-methoxy-2-phenylethyl) piperazin-
1-yl]- 1- phenylpropan- 2-ol) (9873)
(c) Opium derivatives. Any of the following opium derivatives, their
salts, isomers, and salts of isomers, unless specifically excepted by rule
of the board or unless listed in another schedule, whenever the
existence of these salts, isomers, and salts of isomers is possible within
the specific chemical designation:
Acetorphine (9319)
Acetyldihydrocodeine (9051)
Benzylmorphine (9052)
Codeine methylbromide (9070)
Codeine-N-Oxide (9053)
Cyprenorphine (9054)
Desomorphine (9055)
Dihydromorphine (9145)
Drotebanol (9335)
Etorphine (except hydrochloride salt) (9056)
Heroin (9200)
Hydromorphinol (9301)
Methyldesorphine (9302)
Methyldihydromorphine (9304)
Morphine methylbromide (9305)
Morphine methylsulfonate (9306)
Morphine-N-Oxide (9307)
HEA 1182 — Concur 8
Myrophine (9308)
Nicocodeine (9309)
Nicomorphine (9312)
Normorphine (9313)
Pholcodine (9314)
Thebacon (9315)
(d) Hallucinogenic substances. Unless specifically excepted or
unless listed in another schedule, any material, compound, mixture, or
preparation which contains any quantity of the following
hallucinogenic, psychedelic, or psychogenic substances, their salts,
isomers, and salts of isomers whenever the existence of these salts,
isomers, and salts of isomers is possible within the specific chemical
designation (for purposes of this subsection only, the term "isomer"
includes the optical, position, and geometric isomers):
(1) 1-[1-(2-thienyl)cyclohexyl]pyrrolidine (7473). Other name:
TCPy.
(2) 4-Bromo-2, 5-Dimethoxyamphetamine (7391). Some trade or
other names: 4-Bromo-2, 5-Dimethoxy-a-methylphenethylamine;
4-Bromo-2, 5-DMA.
(3) 4-Bromo-2, 5-dimethoxyphenethylamine (7392). Some trade
or other names:
2-[4-bromo-2,5-dimethoxyphenyl]-1-aminoethane;
alpha-desmethyl DOB; 2C-B, Nexus.
(4) 2, 5-Dimethoxy-4-ethylamphet-amine (7399). Other name:
DOET.
(5) 2, 5-Dimethoxy-4-(n)-propylthiophenethylamine (7348).
Other name: 2C-T-7.
(6) 2, 5-Dimethoxyamphetamine (7396). Some trade or other
names: 2, 5-Dimethoxy-a-methylphenethylamine; 2, 5-DMA.
(7) 4-Methoxyamphetamine (7411). Some trade or other names:
4-Methoxy-a-methylphenethylamine; Paramethoxyamphetamine;
PMA.
(8) 5-Methoxy-3, 4-methylenedioxy amphetamine (7401). Other
Name: MMDA.
(9) 5-Methoxy-N, N-diisopropyltryptamine, including any
isomers, salts, or salts of isomers (7439). Other name:
5-MeO-DIPT.
(10) 4-methyl-2, 5-dimethoxyamphetamine (7395). Some trade
and other names: 4-methyl-2,
5-dimethoxy-a-methylphenethylamine; DOM; and STP.
(11) 3, 4-methylenedioxy amphetamine (7400). Other name:
MDA.
HEA 1182 — Concur 9
(12) 3,4-methylenedioxy-N-ethylamphetamine (7404). Other
names: N-ethyl-alpha-methyl-3,4(methylenedioxy)
phenethylamine; N-ethyl MDA; MDE; and MDEA.
(13) 3, 4-methylenedioxymethamphetamine (MDMA) (7405).
(14) 3, 4, 5-trimethoxy amphetamine (7390). Other name: TMA.
(15) Alpha-ethyltryptamine (7249). Some trade and other names:
Etryptamine; Monase; [alpha]-ethyl-1H-indole-3-ethanamine;
3-(2-aminobutyl) indole; [alpha]-ET; and AET.
(16) Alpha-methyltryptamine (7432). Other name: AMT.
(17) Bufotenine (7433). Some trade and other names:
3-(B-Dimethylaminoethyl)-5-hydroxyindole;
3-(2-dimethylaminonethyl)-5-indolol; N, N-dimethylserotonin;
5-hydroxy-N, N-dimethyltryptamine; mappine.
(18) Diethyltryptamine (7434). Some trade or other names: N,
N-Diethyltryptamine; DET.
(19) Dimethyltryptamine (7435). Some trade or other names:
DMT.
(20) Ibogaine (7260). Some trade and other names: 7-Ethyl-6, 6b,
7, 8, 9, 10, 12, 13-octahydro-2-methoxy-6, 9-methano-5H-pyrido
(1', 2': 1, 2, azepino 4, 5-b) indole; tabernanthe iboga.
(21) Lysergic acid diethylamide (7315). Other name: LSD.
(22) Marijuana (7360).
(23) Mescaline (7381).
(24) Methoxetamine[2-(ethylamino)-2-(3-methoxyphenyl)
cyclohexan-1-one or 2-(3-methoxyphenyl)-2-(ethylamino)-
cyclohexanone].
(25) Parahexyl (7374). Some trade or other names:
3-Hexyl-1-hydroxy-7, 8, 9, 10-Tetrahydro-6, 6,
9-trimethyl-6H-dibenzo (b,d) pyran; Snyhexyl.
(26) Peyote (7415), including:
(A) all parts of the plant that are classified botanically as
lophophora williamsii lemaire, whether growing or not;
(B) the seeds thereof;
(C) any extract from any part of the plant; and
(D) every compound, manufacture, salt, derivative, mixture, or
preparation of the plant, its seeds, or extracts.
(27) N-ethyl-3-piperidyl benzilate (7482). Other name: DMZ.
(28) N-hydroxy-3,4-methylenedioxyamphetamine (7402). Other
names: N-hydroxy-alpha-methyl-3,4
(methylenedioxy)phenethylamine; and N-hydroxy MDA.
(29) N-methyl-3-piperidyl benzilate (7484). Other name: LBJ.
(30) Psilocybin (7437).
HEA 1182 — Concur 10
(31) Psilocyn (7438).
(32) Tetrahydrocannabinols (7370), including synthetic
equivalents of the substances contained in the plant, or in the
resinous extractives of Cannabis, sp. and synthetic substances,
derivatives, and their isomers with similar chemical structure and
pharmacological activity such as:
(A) ð
1
 cis or trans tetrahydrocannabinol, and their optical
isomers;
(B) ð
6
 cis or trans tetrahydrocannabinol, and their optical
isomers; and
(C) ð
3,
4 cis or trans tetrahydrocannabinol, and their optical
isomers.
Since nomenclature of these substances is not internationally
standardized, compounds of these structures, regardless of
numerical designation of atomic positions are covered. Other
name: THC.
(33) Ethylamine analog of phencyclidine (7455). Some trade or
other names: N-Ethyl-1-phenylcyclohexylamine;
(1-phenylcyclohexyl) ethylamine; N-(1-phenylcyclohexyl)
ethylamine; cyclohexamine; PCE.
(34) Pyrrolidine analog of phencyclidine (7458). Some trade or
other names: 1-(1-phenylcyclohexyl)-pyrrolidine; PCP
y; PHP.
(35) Thiophene analog of phencyclidine (7470). Some trade or
other names: 1-(1-(2-thienyl) cyclohexyl) piperidine; 2-Thienyl
Analog of Phencyclidine; TPCP.
(36) Salvia divinorum or salvinorin A, including:
(A) all parts of the plant that are classified botanically as salvia
divinorum, whether growing or not;
(B) the seeds of the plant;
(C) any extract from any part of the plant; and
(D) every compound, manufacture, salt, derivative, mixture, or
preparation of the plant, its seeds, or extracts.
(37) 5-Methoxy-N,N-Dimethyltryptamine. Some trade or other
names: 5-methoxy-3-[2- (dimethylamino)ethyl]indole;
5-MeO-DMT.
(38) 2-(2,5-Dimethoxy-4-ethylphenyl)ethanamine (2C-E).
(39) 2-(2,5-Dimethoxy-4-methylphenyl)ethanamine (2C-D).
(40) 2-(4-Chloro-2,5-dimethoxyphenyl) ethanamine (2C-C).
(41) 2-(4-Iodo-2,5-dimethoxyphenyl) ethanamine (2C-I).
(42) 2-[4-(Ethylthio)-2,5-dimethoxyphenyl] ethanamine (2C-T-2).
(43) 2-[4-(Isopropylthio)-2,5-dimethoxyphenyl] ethanamine
(2C-T-4).
HEA 1182 — Concur 11
(44) 2-(2,5-Dimethoxyphenyl) ethanamine (2C-H).
(45) 2-(2,5-Dimethoxy-4-nitro-phenyl) ethanamine (2C-N).
(46) 2-(2,5-Dimethoxy-4-(n)-propylphenyl) ethanamine (2C-P).
(47) Deschloroketamine (2-Phenyl-2-
(methylamino)cyclohexanone).
(48) 4-Hydroxy-MET (4-Hydroxy-N-methyl-N-
ethyltryptamine).
(49) N-methyltryptamine (1H-Indole-3-ethanamine, N-methyl-).
(50) 1-(1,3-benzodioxol-5-yl)-2-(ethylamino)butan-1-one
(other names: eutylone; bk-EBDB (7549)).
(51) N-(1-amino- 3,3-dimethyl-1- oxobutan-2-yl)-
1-butyl-1H-indazole-3- carboxamide (other name:
ADB–BUTINACA) (7027).
(52) 4-methyl-1-phenyl-2-(pyrrolidin-1-yl)pentan-1-one (other
names: á-PiHP; alpha-PiHP) (7551).
(53) 2-(methylamino)-1-(3-methylphenyl)propan-1-one (other
names: 3–MMC; 3-methylmethcathinone) (1259).
(e) Depressants. Unless specifically excepted in a rule adopted by
the board or unless listed in another schedule, any material, compound,
mixture, or preparation which contains any quantity of the following
substances having a depressant effect on the central nervous system,
including its salts, isomers, and salts of isomers whenever the existence
of such salts, isomers, and salts of isomers is possible within the
specific chemical designation:
Etizolam (4-(2- chlorophenyl)-2- ethyl-9- methyl- 6H-
thieno[3,2-f] [1,2,4] triazolo[4,3-a] [1,4diazepine) (other names
include: Etilaam, Etizest, Depas, Etizola, Sedekopan, and
Pasaden)
Flubromazolam (8-bromo-6-(2-fluorophenyl)-1-methyl-
4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine)
Gamma-hydroxybutyric acid (other names include GHB;
gamma-hydroxybutyrate; 4-hydroxybutanoic acid; sodium
oxybate; sodium oxybutyrate) (2010)
Mecloqualone (2572)
Methaqualone (2565)
(f) Stimulants. Unless specifically excepted or unless listed in
another schedule, any material, compound, mixture, or preparation that
contains any quantity of the following substances having a stimulant
effect on the central nervous system, including its salts, isomers, and
salts of isomers:
([+/-]) cis-4-methylaminorex (([+/-])cis-4,5-
dihydro-4-methyl-5-phenyl-2-oxazolamine) (1590).
HEA 1182 — Concur 12
Amineptine (7-[(10,11-dihydro-5H- dibenzo[a,d]cyclohepten- 5-
yl)amino] heptanoic acid) (1219).
Aminorex (1585). Other names: aminoxaphen;
2-amino-5-phenyl-2-oxazoline; or
4,5-dihydro-5-phenyl-2-oxazolamine.
4,4'-Dimethylaminorex (4,4'-DMAR; 4,5-dihydro- 4-methyl-5-(4-
methylphenyl)- 2- oxazolamine; 4-methyl-5- (4-methylphenyl)-
4,5-dihydro-1,3-oxazol- 2-amine).
Benzylone, 1-(1,3-benzodioxol-5-yl)-2-(benzylamino)propan
-1-one. Synonyms: BMDP, N-benzyl methylone,
3,4-Methylenedioxy-Nbenzylcathinone,
N-benzyl-3,4-methylenedioxycathinone.
Cathinone (1235). Some trade or other names:
2-amino-1-phenyl-1-propanone; alpha-aminopropiophenone;
2-aminopropiophenone; and norephedrone.
Fenethylline (1503).
N-Benzylpiperazine (7493). Other names: BZP; and
1-benzylpiperazine.
N-ethylamphetamine (1475).
Mesocarb (N-phenyl-N-(3-(1-
phenylpropan-2-yl)-1,2,3-oxadiazol-3- ium-5yl)carbamimidate)
(1227).
Methcathinone (1237). Some other trade names:
2-Methylamino-1-Phenylpropan-I-one; Ephedrone;
Monomethylpropion; UR 1431.
N, N-dimethylamphetamine (1480). Other names: N,
N-alpha-trimethyl-benzeneethanamine; and N,
N-alpha-trimethylphenethylamine.
Methiopropamine (N-methyl-1- (thiophen-2-yl) propan-2-
amine) (methiopropamine). (1478).
(g) Synthetic drugs as defined in IC 35-31.5-2-321.
SECTION 4. IC 35-48-2-6, AS AMENDED BY P.L.48-2023,
SECTION 5, IS AMENDED TO READ AS FOLLOWS [EFFECTIVE
JULY 1, 2024]: Sec. 6. (a) The controlled substances listed in this
section are included in schedule II.
(b) Any of the following substances, except those narcotic drugs
listed in other schedules, whether produced directly or indirectly by
extraction from substances of vegetable origin, or independently by
means of chemical synthesis, or by combination of extraction and
chemical synthesis:
(1) Opium and opiate, and any salt, compound, derivative, or
preparation of opium or opiate, excluding apomorphine,
HEA 1182 — Concur 13
dextrorphan, nalbuphine, naloxone, naltrexone, and their
respective salts but including:
(A) raw opium (9600);
(B) opium extracts (9610);
(C) opium fluid extracts (9620);
(D) powdered opium (9639);
(E) granulated opium (9640);
(F) tincture of opium (9630);
(G) codeine (9050);
(H) dihydroetorphine (9334);
(I) ethylmorphine (9190);
(J) etorphine hydrochloride (9059);
(K) hydrocodone (9193), and any hydrocodone combination
product, as determined by the federal Food and Drug
Administration;
(L) hydromorphone (9150);
(M) metopon (9260);
(N) morphine (9300);
(O) oxycodone (9143);
(P) oxymorphone (9652);
(Q) thebaine (9333); and
(R) oripavine.
(2) Any salt, compound, isomer, derivative, or preparation thereof
which is chemically equivalent or identical with any of the
substances referred to in subdivision (b)(1) of this section, but not
including the isoquinoline alkaloids of opium.
(3) Opium poppy and poppy straw.
(4) Cocaine (9041). Coca leaves (9040) and any salt,
compound, derivative, or preparation of coca leaves
(including cocaine (9041) and ecgonine (8180) and their salts,
isomers, derivatives, and salts of isomers and derivatives), and
any salt, compound, derivative, or preparation thereof that is
chemically equivalent or identical with these substances
except that the substances do not include:
(A) decocainized coca leaves or an extraction of coca leaves
that does not contain cocaine or ecgonine;
(B) [
123
I]ioflupane; or
(C) [
18
F]FP-CIT.
(5) Concentrate of poppy straw (the crude extract of poppy straw
in either liquid, solid, or powder form which contains the
phenanthrene alkaloids of the opium poppy) (9670).
(c) Opiates. Any of the following opiates, including their isomers,
HEA 1182 — Concur 14
esters, ethers, salts, and salts of isomers, esters, and ethers whenever
the existence of these isomers, esters, ethers, and salts is possible
within the specific chemical designation:
Alfentanil (9737)
Alphaprodine (9010)
Anileridine (9020)
Bezitramide (9800)
Bulk dextropropoxyphene (nondosage forms) (9273)
Carfentanil (9743)
Dihydrocodeine (9120)
Diphenoxylate (9170)
Fentanyl (9801)
Isomethadone (9226)
Levo-alphacetylmethadol (9648). Other names:
Levo-alpha-acetylmethadol; levomethadyl acetate; and LAAM.
Levomethorphan (9210)
Levorphanol (9220)
Metazocine (9240)
Methadone (9250)
Methadone-Intermediate, 4-cyano-2-dimethyl-amino-4,
4-diphenyl butane (9254)
Moramide-Intermediate, 2-methyl-3-morpholino-1,
1-diphenylpropane- carboxylic acid (9802)
Oliceridine (N-[(3-methoxythiophen- 2-yl) methyl]({2- [(9R)-9-
(pyridin- 2-yl)-6-oxaspiro[4.5]decan-9-yl]ethyl})amine) (9245)
Pethidine (Meperidine) (9230)
Pethidine-Intermediate- A, 4-cyano-1-methyl-4-phenylpiperidine
(9232)
Pethidine-Intermediate-B, ethyl-4-phenylpiperidine-4-carboxylate
(9233)
Pethidine-Intermediate-C,1-methyl-4-phenylpiperidine-4-carbo
xylic acid (9234)
Phenazocine (9715)
Piminodine (9730)
Racemethorphan (9732)
Racemorphan (9733)
Remifentanil (9739)
Sufentanil (9740)
Tapentadol
Thiafentanil
(d) Stimulants. Any material compound, mixture, or preparation
which contains any quantity of the following substances having a
HEA 1182 — Concur 15
potential for abuse associated with a stimulant effect on the central
nervous system:
(1) Amphetamine, its salts, optical isomers, and salts of its optical
isomers (1100).
(2) Methamphetamine, including its salts, isomers, and salts of its
isomers (1105).
(3) Phenmetrazine and its salts (1631).
(4) Methylphenidate (1724).
(5) Lisdexamfetamine, its salts, its isomers, and salts of its
isomers.
(e) Depressants. Unless specifically excepted by rule of the board
or unless listed in another schedule, any material, compound, mixture,
or preparation which contains any quantity of the following substances
having a depressant effect on the central nervous system, including its
salts, isomers, and salts of isomers whenever the existence of such
salts, isomers, and salts of isomers is possible within the specific
chemical designation:
Amobarbital (2125)
Glutethimide (2550)
Pentobarbital (2270)
Phencyclidine (7471)
Secobarbital (2315)
(f) Immediate precursors. Unless specifically excepted by rule of the
board or unless listed in another schedule, any material, compound,
mixture, or preparation which contains any quantity of the following
substances:
(1) Immediate precursor to amphetamine and methamphetamine:
Phenylacetone (8501). Some trade or other names:
phenyl-2-propanone; P2P; benzyl methyl ketone; methyl benzyl
ketone.
(2) Immediate precursors to phencyclidine (PCP):
(A) 1-phenylcyclohexylamine (7460); or
(B) 1-piperidinocyclohexanecarbonitrile (PCC) (8603).
(3) Immediate precursor to fentanyl:
(A) 4-anilino-N-phenethylpiperidine (ANPP) (8333); or
(B) N-phenyl-N-(piperidin-4-yl)propionamide (norfentanyl)
(8366).
(g) Hallucinogenic substances:
Dronabinol oral solution. Other name:
(-)-delta-9-trans-tetrahydrocannabinol (delta-9-THC).
Nabilone (7379). Other name: (+/-)-trans-3-
(1,1-dimethylheptyl)-6, 6a, 7, 8, 10, 10a-hexahydro-1-hydroxy -6,
HEA 1182 — Concur 16
6-dimethyl-9H-dibenzo [b,d] pyran-9-one.
SECTION 5. IC 35-48-2-10, AS AMENDED BY P.L.48-2023,
SECTION 6, IS AMENDED TO READ AS FOLLOWS [EFFECTIVE
JULY 1, 2024]: Sec. 10. (a) The controlled substances listed in this
section are included in schedule IV.
(b) Narcotic drugs. Unless specifically excepted in a rule adopted
by the board or unless listed in another schedule, any material,
compound, mixture, or preparation containing any of the following
narcotic drugs, or their salts calculated as the free anhydrous base or
alkaloid, in the following limited quantities:
(1) Not more than 1 milligram of difenoxin (9618) and not less
than 25 micrograms of atropine sulfate per dosage unit.
(2) Dextropropoxyphene (alpha- (+)-4-dimethylamino-1,2-
diphenyl-3-methyl-2-propionoxybutane (9278).
(c) Depressants. Unless specifically excepted in a rule adopted by
the board or unless listed in another schedule, any material, compound,
mixture, or preparation which contains any quantity of the following
substances, including its salts, isomers, and salts of isomers whenever
the existence of such salts, isomers, and salts of isomers is possible
within the specific chemical designation:
Alfaxalone (2731).
Alprazolam (2882).
Barbital (2145).
Brexanolone (2400).
Bromazepam (2748).
Camazepam (2749).
Carisoprodol.
Chloral betaine (2460).
Chloral hydrate (2465).
Chlordiazepoxide (2744).
Clobazam (2751).
Clonazepam (2737).
Clorazepate (2768).
Clotiazepam (2752).
Cloxazolam (2753).
Daridorexant (2410).
Delorazepam (2754).
Diazepam (2765).
Dichloralphenazone (2467).
Estazolam (2756).
Ethchlorvynol (2540).
Ethinamate (2545).
HEA 1182 — Concur 17
Ethyl loflazepate (2758).
Fludiazepam (2759).
Flunitrazepam (2763).
Flurazepam (2767).
Fospropofol (2138).
Halazepam (2762).
Haloxazolam (2771).
Ketazolam (2772).
Lemborexant (2245).
Loprazolam (2773).
Lorazepam (2885).
Lormetazepam (2774).
Mebutamate (2800).
Medazepam (2836).
Meprobamate (2820).
Methohexital (2264).
Methylphenobarbital (mephobarbital) (2250).
Midazolam (2884).
Nimetazepam (2837).
Nitrazepam (2834).
Nordiazepam (2838).
Oxazepam (2835).
Oxazolam (2839).
Paraldehyde (2585).
Petrichloral (2591).
Phenobarbital (2285).
Pinazepam (2883).
Prazepam (2764).
Quazepam (2881).
Remimazolam (2846).
Suvorexant (2223).
Temazepam (2925).
Tetrazepam (2886).
Triazolam (2887).
Zaleplon (2781).
Zolpidem (Ambien) (2783).
Zopiclone (2784).
Zuranolone (2420).
(d) Fenfluramine. Any material, compound, mixture, or preparation
which contains any quantity of the following substances, including its
salts, isomers (whether optical, position, or geometric), and salts of
such isomers, whenever the existence of such salts, isomers, and salts
HEA 1182 — Concur 18
of isomers is possible.
Fenfluramine (1670).
(e) (d) Stimulants. Unless specifically excepted in a rule adopted by
the board or unless listed in another schedule, any material, compound,
mixture, or preparation which contains any quantity of the following
substances having a stimulant effect on the central nervous system,
including its salts, isomers (whether optical, position, or geometric),
and salts of such isomers whenever the existence of such salts, isomers,
and salts of isomers is possible within the specific chemical
designation:
Cathine ((+)-norpseudoephedrine) (1230).
Diethylpropion (1610).
Fencamfamin (1760).
Fenproporex (1575).
Mazindol (1605).
Mefenorex (1580).
Modafinil (1680).
Pemoline (including organometallic complexes and chelates
thereof) (1530).
Phentermine (1640).
Pipradrol (1750).
Serdexmethylphenidate (1729).
Sibutramine (1675).
Solriamfetol (2-amino-3-phenylpropyl carbamate;
benzenepropanol, beta-amino-, carbamate (ester)) (1650).
SPA ((-)-1-dimethylamino-1,2-diphenylethane (1635).
(f) (e) Other substances. Unless specifically excepted or unless
listed in another schedule, any material, compound, mixture, or
preparation which contains any quantity of the following substances
including its salts:
Butorphanol (including its optical isomers) (9720).
Pentazocine (9709).
(g) (f) Tramadol (Ultram).
(h) (g) The board may except by rule any compound, mixture, or
preparation containing any depressant substance listed in subsection
(b), (c), (d), or (e), or (f) from the application of any part of this article
if the compound, mixture, or preparation contains one (1) or more
active medicinal ingredients not having a depressant effect on the
central nervous system, and if the admixtures are included therein in
combinations, quantity, proportion, or concentration that vitiate the
potential for abuse of the substances which have a depressant effect on
the central nervous system.
HEA 1182 — Concur 19
SECTION 6. An emergency is declared for this act.
HEA 1182 — Concur Speaker of the House of Representatives
President of the Senate
President Pro Tempore
Governor of the State of Indiana
Date: 	Time: 
HEA 1182 — Concur